What is a medical advisory board?
A medical advisory board brings together a group of external clinical experts (typically key opinion leaders and practising specialists in the relevant therapy area) to give a pharmaceutical, biotech or MedTech team expert steer on a defined question. Through structured, facilitated discussion, the board explores what experts believe, how they approach treatment in practice, and where current practice sits against the evidence.
In medical affairs and market access, that steer is most valuable early: when a team needs to understand a treatment landscape, test its strategic thinking, or decide where to focus evidence generation before committing to a larger programme of work.
An advisory board is an insight-generating exercise. It sits within Triducive’s wider family of consensus services, alongside structured consensus methods such as the Delphi panel and the nominal group technique.
When to use an advisory board
A pharmaceutical advisory board earns its place when the question is still open – when a team needs direction and insight rather than a measured position. It is typically the right tool for:
Understanding a treatment landscape. Hearing directly how specialists approach diagnosis and treatment in a therapy area, where their views diverge, and how they perceive unmet need – the context every evidence and access strategy depends on.
Testing strategy and assumptions. Putting an evidence plan, value story or clinical development question in front of the experts it ultimately has to convince, and adjusting while adjustment is still inexpensive.
Surfacing evidence gaps. Identifying where the current evidence base is thin, what would genuinely change practice, and what evidence would need to exist for it to do so. The open questions an advisory board surfaces often go on to define the statements a later consensus study tests.
Exploring beliefs and current practice. Gaining a candid read on how a topic is actually handled in clinic, as distinct from how guidelines assume it is handled.
It is equally important to be clear about what an advisory board is not. Its discussion is exploratory and its output is insight and direction: it does not produce a measured level of expert agreement, and it is not designed for peer-reviewed publication. Where a defensible, publishable consensus position is the goal, a structured method such as a Delphi panel is the appropriate route.
